Non-myeloablative matched sibling stem cell transplantation with the optional reinforced stem cell infusion for patients with hemoglobinopathies.

Seung Hwan ShinSung-Soo ParkSilvia ParkYoung-Woo JeonSung Soo Park Seung-Ah YahngByung-Sik ChoYoo-Jin KimSeok LeeHee-Je KimChang-Ki MinSeok-Goo ChoDong-Wook KimJong-Wook LeeKi-Seong Eom

Published in: European journal of haematology (2020)

This study is the first to report successful NMA conditioning alloSCT to achieve stable mixed chimerism correcting the abnormal hemoglobin phenotype in adult β-TM patients.

Keyphrases

stem cell transplantation
stem cells
high dose
end stage renal disease
newly diagnosed
chronic kidney disease
allogeneic hematopoietic stem cell transplantation
low dose
prognostic factors
acute lymphoblastic leukemia